IP Library Granted Patent US 9,131,874
Granted Patent B2
US 9,131,874 · App. 13/642,465 · Granted Sep 15, 2015

Fluoroscopy-independent, endovascular aortic occlusion system

Inventors: Jonathan L. Eliason (Ann Arbor, MI); Todd E. Rasmussen (Fair Oaks Ranch, TX)
Assignees: THE REGENTS OF THE UNIVERSITY OF MICHIGAN; The United States of America as represented by the Secretary of the Air Force
A61B5/1076A61B5/6851A61B17/12031A61M25/04A61M25/09A61B5/1072A61B5/1075A61M2025/0008A61M2025/0081A61M2025/09183A61M2025/1052B42D15/0006B42D15/0086G01B3/1084
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,131,874
App. No.
13/642,465
Granted
Sep 15, 2015
Kind
B2
Abstract

A system for deploying and selectively inflating a thoracic aortic balloon at a desired location within the thoracic aorta for resuscitative aortic occlusion, inferior to the left subclavian artery, without the aid of fluoroscopy is described. Using CT imaging data, a distance between readily identifiable and consistently located external landmarks of torso extent is measured. Next, using the same data, a second distance from the femoral artery to a desired aortic occlusion location inferior to the left subclavian artery is determined. A correlation between the external measure of torso extent and the desired intra-arterial (i.e. endovascular) distance within the torso is made. Using a nomogram, a calibrated endovascular resuscitative thoracic aortic occlusion system can be positioned to this desired location on any injured individual with end-stage shock and impending cardiovascular collapse or death without the aid of fluoroscopy for delivery or balloon inflation.

Claims (12)

1. A thoracic aortic occlusion system comprising:

an endovascular wire;

a balloon shaft comprising an aortic occlusion balloon on a distal end of the balloon shaft and a lumen to permit the balloon shaft to pass over the endovascular wire when the endovascular wire and the balloon shaft are inserted into a femoral artery at a femoral head of a patient; and

a nomogram comprising one of a table, chart or graph correlating distances between at least two external anatomical landmarks of each human of a pool of humans to centerline distances from the femoral artery at the femoral head to a location within a thoracic aorta of each of the humans, where a distance between at least two anatomical landmarks is measured on a patient and compared to the distances between the at least two external anatomical landmarks on the nomogram to calculate a length to which the endovascular wire and the balloon shaft are to be inserted in the patient such that the aortic occlusion balloon is positioned at a desired location within the thoracic aorta without using fluoroscopy.

2. The system of claim 1 , wherein the location within the thoracic aorta coincides with an aortic branch artery landmark.

3. The system of claim 1 , wherein the location within the thoracic aorta is inferior to the origin of the left subclavian artery.

4. A method for deploying and selectively inflating a thoracic aortic balloon at a desired location within a thoracic aorta of a patient, comprising:

measuring a distance between at least two readily externally identifiable anatomical landmarks of the patient, said anatomical landmarks including at least a symphysis pubis of the patient and a sternal notch of the patient;

comparing the distance between the at least two external anatomical landmarks of the patient to a prediction model and calculating a length to which a calibrated endovascular wire and a balloon shaft of the thoracic occlusion system are to be inserted in the patient, the prediction model having correlation data for distances between the at least two external anatomical landmarks of torso extent of a pool of humans to centerline distances from a femoral artery at a femoral head to a location within the thoracic aorta of humans, the data measured using CT imaging; and

inserting the calibrated endovascular wire and the balloon shaft to the length calculated for the patient independent of fluoroscopy.

5. The method of claim 4 , wherein the prediction model is one of a table, a chart, a graph, or a nomogram.

6. The method of claim 4 , wherein the method further includes pre-securing the balloon shaft to the endovascular wire proximate a trailing securement bead, allowing the balloon shaft and the endovascular wire to be inserted in the patient and delivered as a single unit.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2024
From: REGENTS OF THE UNIVERSITY OF MICHIGAN
To: REGENTS OF THE UNIVERSITY OF MICHIGAN; THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERAN AFFAIRS
Reel/Frame 068553/0880 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2023
From: THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE
To: THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE DIRECTOR OF THE DEFENSE HEALTH AGENCY
Reel/Frame 065779/0620 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2012
From: RASMUSSEN, TODD E.
To: GOVERNMENT OF THE UNITED STATES C/O SECRETARY OF THE AIR FORCE
Reel/Frame 029168/0217 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2012
From: ELIASON, JONATHAN L.
To: REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 029168/0338 →
Continuity (2)
Provisional Application 61326478 · Apr 21, 2010
Related Publication 20130102926A1 · Apr 25, 2013